ALVESCO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, UK.

Active ingredients

The drug ALVESCO contains one active pharmaceutical ingredient (API):

1	Ciclesonide UNII S59502J185 - CICLESONIDE
	Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor. Once orally inhaled, ciclesonide is enzymatically converted in the lungs to the principal metabolite (C21-des-methylpropionyl-ciclesonide) which has a pronounced anti-inflammatory activity and is thus considered as the active metabolite.
	Read more about Ciclesonide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALVESCO 80 Pressurised inhalation, solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA08	Ciclesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8853Y, 8854B
BR	Câmara de Regulação do Mercado de Medicamentos	501103801170316, 501103901175311
CA	Health Products and Food Branch	02285606, 02285614
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02484858, 02787033, 02787091, 02787116, 03418935, 03418958, 03736894, 03895463, 05909330, 06103882, 06103936, 06103942, 06562101, 06573837, 06934620, 06934790, 07717592, 07717600, 07753151, 08839587, 09156264, 09176019, 09202308, 10073193, 10298839, 10298845, 10301292, 10525956, 11647029, 12567976, 16060145, 16792894, 16812042, 16923445, 17204416
EE	Ravimiamet	1156328, 1156339, 1156340, 1239577, 1239588, 1239599, 1239612, 1239623, 1322862, 1322873, 1322884, 1441987
ES	Centro de información online de medicamentos de la AEMPS	70372
FI	Lääkealan turvallisuus- ja kehittämiskeskus	032105, 032141, 032178, 032214
FR	Base de données publique des médicaments	63599556, 66052179
GB	Medicines & Healthcare Products Regulatory Agency	180506, 299591, 299595, 375772, 377402, 90040, 90043, 93425
HK	Department of Health Drug Office	53034, 53035
HR	Agencija za lijekove i medicinske proizvode	HR-H-058422961
IE	Health Products Regulatory Authority	11807, 11951
JP	医薬品医療機器総合機構	2290702G1025, 2290702G2021, 2290702G3028, 2290702G4024
LT	Valstybinė vaistų kontrolės tarnyba	1016744, 1016745, 1016746, 1022811, 1022812, 1022813, 1022814, 1028368, 1033353, 1052058, 1052059
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	456M2004
NL	Z-Index G-Standaard	15049159, 15049175
NL	Z-Index G-Standaard, PRK	77674, 77690, 87041, 87939
NZ	Medicines and Medical Devices Safety Authority	11092, 11093
PL	Rejestru Produktów Leczniczych	100133028, 100133034, 100463764
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67522001, W67522002, W67522003, W67523001, W67523002, W67523003
SG	Health Sciences Authority	13233P, 13234P
US	FDA, National Drug Code	70515-711, 70515-712
ZA	Health Products Regulatory Authority	37/21.5.1/0530, 37/21.5.1/0531